Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study.

Diabetes Care · 2015 · PMC4542273 · PMID 26153271

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Reductions in insulin and TNF-α relative to placebo and increases in adiponectin relative to placebo were observed ( Table 3 ) but did not reach statistical significance on the overall ANCOVAs.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.